William Pickering
Stock Analyst at Bernstein
(2.85)
# 1,326
Out of 4,435 analysts
15
Total ratings
66.67%
Success rate
4.14%
Average return
Main Sectors:
Top Industries:
10 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Initiates: Outperform | $1,125 | $987.27 | +13.95% | 1 | Mar 12, 2024 | |
| VRTX Vertex Pharmaceuticals | Downgrades: Market Perform | n/a | $445.87 | - | 5 | Feb 2, 2024 | |
| BMRN BioMarin Pharmaceutical | Upgrades: Market Perform | $82 | $77.05 | +6.42% | 2 | Oct 23, 2023 | |
| ALNY Alnylam Pharmaceuticals | Initiates: Outperform | $243 | $150.24 | +61.74% | 1 | Mar 21, 2023 | |
| NTLA Intellia Therapeutics | Initiates: Outperform | $54 | $25.89 | +108.57% | 1 | Mar 21, 2023 | |
| BEAM Beam Therapeutics | Initiates: Market Perform | $37 | $24.84 | +48.95% | 1 | Mar 21, 2023 | |
| ALLO Allogene Therapeutics | Initiates: Market Perform | $6 | $2.59 | +131.66% | 1 | Mar 21, 2023 | |
| CRSP CRISPR Therapeutics AG | Initiates: Market Perform | $44 | $55.47 | -20.68% | 1 | Mar 21, 2023 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Market Perform | $27 | $24.82 | +8.78% | 1 | Mar 21, 2023 | |
| IONS Ionis Pharmaceuticals | Initiates: Underperform | $31 | $38.72 | -19.94% | 1 | Mar 21, 2023 |
Regeneron Pharmaceuticals
Mar 12, 2024
Initiates: Outperform
Price Target: $1,125
Current: $987.27
Upside: +13.95%
Vertex Pharmaceuticals
Feb 2, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $445.87
Upside: -
BioMarin Pharmaceutical
Oct 23, 2023
Upgrades: Market Perform
Price Target: $82
Current: $77.05
Upside: +6.42%
Alnylam Pharmaceuticals
Mar 21, 2023
Initiates: Outperform
Price Target: $243
Current: $150.24
Upside: +61.74%
Intellia Therapeutics
Mar 21, 2023
Initiates: Outperform
Price Target: $54
Current: $25.89
Upside: +108.57%
Beam Therapeutics
Mar 21, 2023
Initiates: Market Perform
Price Target: $37
Current: $24.84
Upside: +48.95%
Allogene Therapeutics
Mar 21, 2023
Initiates: Market Perform
Price Target: $6
Current: $2.59
Upside: +131.66%
CRISPR Therapeutics AG
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $55.47
Upside: -20.68%
Arrowhead Pharmaceuticals
Mar 21, 2023
Initiates: Market Perform
Price Target: $27
Current: $24.82
Upside: +8.78%
Ionis Pharmaceuticals
Mar 21, 2023
Initiates: Underperform
Price Target: $31
Current: $38.72
Upside: -19.94%